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Abstract
With the development of new technologies and drugs, health care
is becoming increasisngly complex and expensive. Governments
and health care providers around the world devote a large
proportion of their budgets to maintaining quality of care. During
2007,  Critical Care published several papers that highlight
important aspects of critical care management, which can be
subdivided into structure, processes and outcomes, including
costs. Great emphasis was given to quality of life after intensive
care unit stay, especially the impact of post-traumatic stress
disorder. Significant attention was also given to staffing level,
optimization of intensive care unit capacity, and drug cost-
effectiveness, particularly that of recombinant human activated
protein C. Managing costs and providing high-quality care
simultaneously are emerging challenges that we must understand
and meet.
Introduction
With the development of new technologies and drugs, health
care is becoming increasingly complex and expensive. Govern-
ments and health care providers around the world devote a
large proportion of their budgets to maintaining quality of
care. Growing concern over patient care and safety has
prompted initiatives such as The 5 Million Lives Campaign, a
voluntary initiative to protect patients from 5 million incidents
of medical harm between December 2006 and December
2008 [1]. With the dawn of a new era focusing on quality and
patient safety, the responsibility for overseeing quality is more
clearly recognized as a priority for health care organizations.
One must measure to control, and one must control to manage
[2]. This is the mainstay of quality, and therefore indicators (units
of measurement) must be identified for each management
situation. However, these indicators must be well understood
and must focus on the primary outcomes of interest. If one
evaluates the wrong factors along the way, then unexpected
and misleading results may emerge [3]. We therefore structured
this review of last year’s Critical Care papers related to intensive
care unit (ICU) management, dividing them into the primary
categories of structure and processes, naturally leading on to
outcomes, including cost issues.
Structure
Structure includes the physical aspects of the ICU,
biomedical equipment (beds, monitors, ventilators and other
devices) and how the multidisciplinary team is organized.
Organization includes both quantity and quality of staffing,
and the leadership taken by the ICU medical team regarding
medical decisions (for instance, open versus closed units).
Availability of technology alone does not assure quality of
care. Manpower (staffing level) appears to be a fundamental
component, as indicated by Hugonnet and colleagues [4]. In
their prospective cohort study, the fourth quartile of nurse-to-
patient ratio (>2.2) was associated with lower risk for late-
onset ventilator-associated pneumonia (hazard ratio = 0.42,
95% confidence interval = 0.18 to 0.99). This observation is
consistent with various adverse factors associated with
reduced staffing that can lead to inadequate care in
ventilated patients: multiple opportunities for cross-contami-
nation, increased workload, low compliance with hand
hygiene recommendations and a stressful environment.
During the period of study, the median nurse-to-patient ratio
was 1.9 (interquartile range 1.8 to 2.2) [4,5].
In general, the ideal nurse-to-patient ratio is difficult to
estimate, given the heterogeneity of data reported in the
literature [6-8] and wide variation in local policies and
practices. There is a growing need for further research
specifically examining relationships between staffing models
and outcomes.
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An interesting safety issue in ICU care was the focus of a
study by van Lieshout and colleagues [9], namely the impact
of electromagnetic interference by next-generation mobile
phones on critical care medical equipment. Episodes of
electromagnetic interference were identified in 43% of 61
critical care medical devices, and 33% of these episodes
were classified as hazardous (total switch off and restart of a
mechanical ventilator, complete stop of syringe pumps
without alarm, and incorrect pulsing by external pacemaker).
van Lieshout and colleagues recommend a policy of keeping
mobile phones at least 1 m from the critical care bedside,
combined with easily accessed areas in which mobile phone
use is unrestricted.
Processes
Processes may be understood as specific approaches to the
delivery of health care, and these areas are important targets
for quality improvement in the ICU. Approaches to process
improvement include (but are not limited to) use of protocols
and care bundles, and capacity optimization.
Issues related to rationing of ICU care are gaining attention in
the literature [10-12]. Rationing may be defined as allocation
of health care resources in the face of limited availability,
which necessarily means that beneficial interventions are
withheld from some individuals [11]. Some studies conducted
in ICUs have documented high rates of refusal to admit
because of lack of available beds [13,14]. This is a discussion
that leads to numerous ethical conflicts and to a need to
identify ways to optimize ICU capacity. In a retrospective study
conducted at Erasmus University Medical Center, The
Netherlands, Van Houdenhoven and coworkers [15] created
and validated three models that incorporate characteristics of
individual patients who underwent oesophagectomy for
cancer to predict length of stay (LOS) in the ICU. The authors
concluded that it is possible to predict LOS and optimize ICU
occupancy, yielding more efficient use of ICU beds and better
quality of care as a result of fewer cancellations of surgical
procedures. However, the best model used data acquired
during the first 72 hours of ICU admission, which limits its use
before procedures have been applied.
Evidence-based protocols are known to minimize errors and
adverse effects, but even simple procedures, such as taking a
conservative approach to red blood cell (RBC) transfusions,
are difficult to implement and strongly influenced by
physicians’ personal convictions [16]. Understanding the
adverse effects of a procedure may be important in justifying
unit protocols that restrict its use. A secondary analysis of a
multicentre, prospective cohort of critically ill patients [17]
indicated that RBC transfusion is associated with an
increased risk for developing acute respiratory distress
syndrome (ARDS), with a dose-response relationship. Among
4,730 patients without ARDS at admission, 246 (5.2%)
developed ARDS in the ICU. On average, patients
developing ARDS received significantly more blood than did
control patients (3.8 units versus 1.8 units per patients
transfused; P < 0.0001), and there was a significant associa-
tion between RBC transfusion and ARDS development
(adjusted odds ratio = 2.8), with a clear dose-response
relationship. The likely cause and effect relationship between
RBC transfusion and ARDS is supported by the TRICC
(Transfusion Requirements in Critical Care) study [18], which
compared a conservative (7 g/dl) versus a liberal (10 g/dl)
transfusion threshold. This study identified a 7.7% incidence
of ARDS with the conservative threshold versus 11.4% with
the liberal threshold (P = 0.06).
Outcomes
The final point in the quality improvement process is to
describe the results, in terms of the primary outcomes. There
are many important outcomes critical care, including mortality
and LOS, but other factors are receiving research attention.
These include quality of life (QoL) outcomes after ICU
discharge (including functional and psychosocial recovery)
[19] and cost. Indeed, the concept of value is related to
providing the best possible quality at the lowest possible
cost. Therefore, when two ICUs provide the same level of
care, the most valuable one is that which is least expensive.
Modelling mortality has been used for many years in critical
care [20-23] for benchmarking, process improvement and
standardizing illness severity in clinical studies. An interesting
report by Hofhuis and colleagues [24] explored the influence
of QoL before ICU admission, assessed using the 36-item
Short Form questionnaire, in terms of predicting mortality.
Those investigators followed a prospective cohort in a
university-affiliated teaching hospital and compared the ability
of 36-item Short Form components to predict 6-month
mortality as compared with that of the Acute Physiology and
Chronic Health Evaluation (APACHE) II scoring system. The
authors concluded that pre-admission health-related QoL in
critically ill patients is as good as APACHE II scores in
predicting 6-month mortality. The models studied were more
specific (81% to 84%) than sensitive (44% to 56%) [24],
similar to other validated scoring systems [25]. However, the
models did not meet standard thresholds for discrimination,
because all areas under the receiver operating characteristic
curves were under 0.80. Several limitations were noted: the
APACHE II system was intended for use in predicting in-
hospital mortality and not long-term mortality, and only
patients with an ICU stay longer than 48 hours were included.
Finally, it is unclear how accurate proxy assessments of pre-
admission health-related QoL are, especially for items relating
to mental health function.
Whether advances in acute care can be translated into long-
term benefits remains unclear, especially in chronically
critically ill patients. In a retrospective observational study
conducted in Germany, Hartl and colleagues [26] analyzed
changes in acute and long-term mortality in surgical patients
with an ICU stay longer than 28 days. The overall ICU survivalPage 3 of 6
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rate was 54%, with survival rates at 1, 3 and 5 years of 62%,
45% and 37%, respectively, among ICU survivors. This study
showed that acute mortality is determined by disease severity
during the ICU stay and by pre-existing illnesses, whereas
long-term survival mostly depends on underlying disease. Age
was a significant factor in both analyses. Interestingly, the
authors were also able to demonstrate that both acute and
long-term outcomes in this specific population did not differ
over 2 decades in their institution, which is in contrast to
several other studies that showed improved outcomes over
time in populations of patients with severe sepsis [27,28].
Prolonged mechanical ventilation (PMV) is an important
outcome in critical care because of the associated resource
utilization. However, clear definitions for PMV and chronic
critical illness have been lacking in the literature. In a
prospective cohort of 817 patients mechanically ventilated
for 48 hours or more, of whom 293 were PMV patients, Cox
and coworkers [29] compared 1-year health outcomes
(survival, functional status, QoL and hospital costs) between
two common PMV definitions. These definitions were
ventilation for ≥21 days in total, with ventilation discontinued
for no more than 48 hours; and diagnosis-related group 541
and 542, involving mechanical ventilation for more than 96
hours and a tracheostomy. They also compared outcomes
between PMV patients and those ventilated for shorter
periods of time. The investigators found that PMV defined as
mechanical ventilation for ≥21 days more specifically
identified those who are outliers in terms of resource
consumption from among ventilated patients. One-year
mortality in patients ventilated for longer than 21 days was
similar to that in patients receiving mechanical ventilation for
shorter periods. Between the two PMV definitions, the one
using diagnosis-related group 541/542 selects those
patients who have lower illness severity, lower mortality and
lower hospital costs, as compared with the definition invol-
ving  ≥21 days of mechanical ventilation. PMV patients
experienced persistent ICU-associated functional disability, at
great cost.
Patients who survive critical illness often report poor QoL and
exhibit symptoms of post-traumatic stress disorder (PTSD)
[30]. Studies conducted in long-term survivors of ICU
treatment identified clear and vivid recall of various categories
of traumatic memory, such as nightmares, anxiety, respiratory
distress, or pain, with little or no recall of factual events. A
high number of these traumatic memories from the ICU have
been shown to be a significant risk factor for later
development of PTSD in long-term survivors [19]. The
relationship between critical illness and PTSD has been
assessed in few studies over the past decade, with reported
prevalence rates ranging from 5% to 63%. The highest
prevalence rates were reported in small studies, and loss to
follow up ranged from 10% to 70% [31]. In a cohort of 100
patients with secondary peritonitis, of whom 61 were
admitted to the ICU, the overall prevalence of long-term
PTSD using Post-Traumatic Stress Syndrome-10 question-
naires was 24% [32]. ICU admission per se was significantly
associated with PTSD after controlling for other factors
related to PTSD (age, sex and APACHE II score). Older age
and male sex were associated with a lower incidence of
PTSD [32,33], whereas higher APACHE II score, mechanical
ventilation [32] and administration of higher doses of
lorazepam [33] were associated with a greater incidence.
Although the latter could either indicate causation or simply
be a marker for acute anxiety, long-term follow up of a
randomized study of daily interruption to sedation [34]
indicated that this strategy may decrease PTSD symptoms. In
an era in which mental health professionals are beginning to
recognize the significant costs [35] associated with this
psychiatric syndrome, understanding the relationship between
critical illness and PTSD is a challenge that demands
attention and better designed studies [31].
ICU organization and pathology-specific volume of patients
may influence outcome [36]. Several studies tried to identify
the volume-outcome relationship in ICU patients [37,38].
Some failed to identify any such relationship [39], but others -
such as a retrospective cohort study from The Netherlands
[40] - found important associations. They studied mortality
among 4,605 patients with severe sepsis admitted to 28
different ICUs, and they found that a higher annual volume is
associated with lower in-hospital mortality in this group of
patients (odds ratio = 0.970, 95% confidence interval =
0.943 to 0.997; P = 0.029); the upper quartile of sepsis
admissions was 96 patients/year and, compared with the
lower quartile (38 patients/year), the absolute risk for in-
hospital mortality was 3% to 4% lower. Interestingly, this
study also demonstrated a higher risk for in-hospital mortality
when step-down units were present in hospitals; this finding
warrants further study. Adequate structure [41] and staffing
levels [4-8], and well established and understood processes
[42,43] that are associated with higher volumes of specific
patient types may reduce ICU and in-hospital mortality.
Another approach to improving quality of care is to reduce
missed diagnoses by analyzing discrepancies between pre-
mortem and post-mortem diagnoses. A retrospective review
of medical records and autopsy reports in critically ill cancer
patients was undertaken in an oncologic ICU in the USA
[44]. Missed diagnoses with potential impact on treatment
and survival were noted in 26% of autopsies. Most
discrepancies were due to opportunistic infections (viral,
bacterial, fungal and parasitic) and cardiopulmonary compli-
cations. Lung infections were the most prevalent, followed by
central nervous system, gastrointestinal and disseminated
infectious disease. Ischaemic cardiomyopathy, thrombotic
endocarditis, congestive heart failure and pulmonary embo-
lism were identified as cardiopulmonary missed diagnoses.
Another study enrolling critically ill patients [45] found that
post-mortem findings were in complete agreement with pre-
mortem diagnoses in fewer than half of cases (n = 17 [45%]).
Available online http://ccforum.com/content/12/5/229Major missed diagnoses were present in 15 cases (39%).
Myocardial infarction, carcinoma and pulmonary embolism
represented the most frequently missed diagnoses, which is
clearly different from the former study and probably highlights
differences between the two populations. These findings
further confirm the importance of the post-mortem examina-
tion in determining an accurate cause of death and in
continuously improving and renewing the search for
alternative diagnostic hypotheses during the course of critical
illness, especially in immunosuppressed patients. Autopsy
remains an important tool for education and quality control.
Costs
Critical care services represent a large and growing propor-
tion of health care expenditure [11]. It may be influenced by
LOS, severity of illness, presence of sepsis, ventilator-
associated pneumonia, the level of hospital care, drug costs
and staffing levels. Several studies have shown that severity
of illness has a large impact on ICU costs [46-50]. A German
national prevalence study examining the costs of critical care
[51] revealed that, in the studied population, 10% of all
patients consumed about 19% of total resources. In all levels
of hospital care, the most expensive patients were those who
required mechanical ventilation, those with greater severity of
illness and/or severe sepsis, those admitted for emergency
surgical procedures and nonsurvivors.
Ventilator-associated pneumonia probably also influences
costs, because it is associated with increased duration of
mechanical ventilation (by 5 to 7 days) and longer hospital
LOS [4]. Hospital costs in patients receiving PMV are
substantially higher than in patients ventilated for shorter
periods, and up to 41% of PMV patients receive potentially
ineffective care [29].
Staffing levels contribute to a major proportion of ICU costs
(56.1% on average overall) [51]. Neverthless, there is
growing evidence that high workload and low staffing level
increases the risk for negative patient outcomes such as
death and nosocomial infection [4-8]. Thus, finding an
adequate staff-to-patient ratio that neither increases costs nor
decreases quality of assistance and patient safety is the
answer to this cost-effectiveness question.
New and expensive drugs also have a major impact on ICU
costs, but they are often not adequately evaluated for cost-
effectiveness [52,53]. A prospective observational study was
conducted in France to evaluate the cost-effectiveness of
recombinant human activated protein C (rhAPC) in severe
sepsis and multiple organ failure [54]. They used propensity
scores to match patients before and after rhAPC was
licensed for use in France, thus avoiding selection bias from
the original randomized controlled trial. The study concluded
that there was a 74% probability that the use of rhAPC would
be cost-effective if there were willingness to pay €50,000
per life-year gained and a 64.3% probability if there were
willingness to pay €50,000 per quality-adjusted life-year
gained. An important difference between this study and other
studies examining the cost-effectiveness of rhAPC [55,56] is
that they did not demonstrate as large an effect size in their
actual practice population as was seen in the PROWESS
(Recombinant Human Activated Protein C Worldwide
Evaluation in Severe Sepsis) trial.
Conclusion
Last year’s Critical Care papers dealt with several aspects of
ICU management, including quality, safety and cost
management. Rational use of drugs, optimization of ICU
capacity, mechanical ventilation and its complications, and
adequate staffing levels are important factors that should be
highlighted in efforts to improve the quality of care delivered
to patients during an ICU stay and after discharge. Managing
costs and providing high quality of care simultaneously are
emerging challenges that must be understood and met.
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